Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gen Digital Inc. Common Stock (GEN) vs Moderna, Inc. (MRNA) Price & Performance

Gen Digital Inc. Common StockTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Gen Digital Inc. Common Stock vs Moderna, Inc. — how do they compare? Gen Digital Inc. Common Stock trades at $22.97 (market cap $13.61B), while Moderna, Inc. trades at $220.17 (market cap $78.65B). The key difference: Moderna, Inc. is far larger — about 5.8× Gen Digital Inc. Common Stock's market cap, and Gen Digital Inc. Common Stock pays a 2.2% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gen Digital Inc. Common Stock for 1 Days and Moderna, Inc. for 59 Days on average.

GENMRNA
Market Cap
$13.61B$78.65B
Volume
10,697,88337,373,437
Sector
TechnologyHealth
52-Week High
$31.41$203.46
52-Week Low
$17.89$22.36
Typical Hold Time
1 Days59 Days
Enterprise Value
$21.25B$74.80B
Dividend Yield
2.2%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gen Digital Inc. Common Stock

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.

Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEN

No sentiment data available yet.

MRNA
53% Buy47% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Gen Digital Inc. Common Stock

Gen Digital provides cybersecurity, online privacy, identity protection, and financial wellness services. Its consumer brands include Norton, Avast, LifeLock, and MoneyLion.

Read more on GEN →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →